Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit ...Middle East

Fortune - News
Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit
GSK said the outcome is “consistent with the scientific consensus that there is no consistent or reliable evidence” of increased cancer risks from Zantac.

Hence then, the article about victory for drugmakers gsk and boehringer in 640 million zantac cancer lawsuit was published today ( ) and is available on Fortune ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit )

Apple Storegoogle play

Last updated :

Also on site :